FACULTY:
Nathan Wiederhold, PharmD is a professor and director of the Fungus Testing Laboratory at UT Health San Antonio,
OVERVIEW:
Aspergillus is rare in healthy kids, but for immuno-compromised patients, early recognition is critical. In Part 2 of our Think Fungus series, host Holly Wayment talks with Nathan Wiederhold, PharmD, director of the Fungus Testing Laboratory at UT Health San Antonio, about which children are most at risk and the clues that should make pediatricians think fungus.
Why is antifungal resistance climbing worldwide, and could a farm field be part of the problem? Which lab tests change care? And what new drugs are finally on the horizon? Dr. Wiederhold breaks it all down, plus practical advice for the tough, treatment-resistant cases.
The Fungus Testing Laboratory at UT Health San Antonio can be reached at: 210-567-4086
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Speaker: Nathan Wiederhold, PharmD has disclosed he is a researcher for Basilea, Bruker, F2G, Elion, Mycovia, and Scynexis; and a consultant/advisor for F2G. The relevant financial relationships noted for Dr. Wiederhold have been mitigated.
The Pediatrics Now Podcast Planning Committee members: Steven Seidner, MD, and Holly Wayment have no relevant financial relationships with ineligible companies to disclose.
The University of Texas at San Antonio and Steven Seidner, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas at San Antonio designates this enduring material up to a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
10/23/2026
EXPIRATION DATE:
8/31/2029